Streptozocin
Zanosar
Alkylating Drug
NADAC/unit
N/A
Active Shortage
Streptozocin damages cancer cell DNA to prevent tumor growth.
Active Shortages
2022-07-12 Shortage reported, ESTEVE PHARMACEUTICALS, S.A.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.